Meeting
2015 ASCO Annual Meeting
Prospective validation of cerebrospinal fluid (CSF) circulating tumor cells (CTC) to diagnose leptomeningeal metastasis (LM) from epithelial tumors.
Authors
Xuling Lin
Memorial Sloan Kettering Cancer Center, New York, NY
Xuling Lin , Martin Fleisher , Antonio Marcilio Padula Omuro , Larisa Shagabayeva , Elena Pentsova
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 33, 2015 (suppl; abstr 2072)
DOI
10.1200/jco.2015.33.15_suppl.2072
Abstract #
2072
Poster Bd #
62
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A phase Ia/Ib study of intrathecal deferoxamine in patients with leptomeningeal metastases.
First Author: Jessica Wilcox
Poster
2020 ASCO Virtual Scientific Program
Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF).
First Author: Kathleen Fenn
Poster
2024 ASCO Annual Meeting
The clinical utility of a circulating tumor cell based cerebrospinal fluid assay in the diagnosis and molecular analysis of leptomeningeal disease in patients with metastatic non-small cell lung cancer.
First Author: Ramya Muddasani
Poster
2024 ASCO Annual Meeting
Identification of pharmaceutics with selective activity against melanoma-associated leptomeningeal disease using patient-derived circulating tumor cells.
First Author: Vincent Law